Patho.Ai
Patho.Ai provides an end-to-end platform that speeds up cancer drug development using AI. It uses custom LLMs and AI agents built on Mol-Bert and leverages Alphafold2, with an on-premise LLM FPGA option delivering private, faster computation (claimed 100x speedup versus cloud GPUs). The platform supports SaaS, licensing, and hardware sales to cancer researchers and life science organizations, with data privacy and IP protection on optimized hardware. Partnerships with DataBrick enhance data analytics and AI-driven discovery to reduce time, cost, and uncertainty in drug discovery at scale.
Patho.Ai
Patho.Ai provides an end-to-end platform that speeds up cancer drug development using AI. It uses custom LLMs and AI agents built on Mol-Bert and leverages Alphafold2, with an on-premise LLM FPGA option delivering private, faster computation (claimed 100x speedup versus cloud GPUs). The platform supports SaaS, licensing, and hardware sales to cancer researchers and life science organizations, with data privacy and IP protection on optimized hardware. Partnerships with DataBrick enhance data analytics and AI-driven discovery to reduce time, cost, and uncertainty in drug discovery at scale.